Current approved therapeutic strategies for IPF and LC treatment
4.5 (273) · $ 27.50 · In stock
Frontiers Potential targeted therapy based on deep insight into the relationship between the pulmonary microbiota and immune regulation in lung fibrosis
PDF) Molecular Mechanisms and Cellular Contribution from Lung
Massimo DOMINICI Università degli Studi di Modena e Reggio
Anna SAMARELLI Università degli Studi di Modena e Reggio Emilia
Alessandro MARCHIONI Università degli Studi di Modena e Reggio
MiR-326-mediated overexpression of NFIB offsets TGF-β induced epithelial to mesenchymal transition and reverses lung fibrosis
Discovery of Novel Selective and Orally Bioavailable Phosphodiesterase-1 Inhibitors for the Efficient Treatment of Idiopathic Pulmonary Fibrosis
hucMSCs treatment prevents pulmonary fibrosis by reducing circANKRD42-YAP1-mediated mechanical stiffness
Linda Manicardi's research works Polyclinic of Modena, Modena
Idiopathic pulmonary fibrosis - ScienceDirect
Cellular Senescence in Idiopathic Pulmonary Fibrosis
A Review of the Treatment and Management of Idiopathic Pulmonary Fibrosis
PDF) Current Treatment Strategies for Non-Small-Cell Lung Cancer with Comorbid Interstitial Pneumonia
Stefania CERRI, Assistant Professor, MD, PhD